David Erritzoe

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (14)

Abhishekh Ashok

Academic Clinical Lecturer

University of Cambridge

UNITED KINGDOM

View details

Philip Corlett

Assistant Professor

Yale University

UNITED STATES

View details

Danilo Arnone

King’s College London

UNITED KINGDOM

View details

Per Carlbring

Adjunct Professor in e-Health

University of Southern Denmark

DENMARK

View details

Sameer Jauhar

King’s College London

UNITED KINGDOM

View details

Rachel Upthegrove

Professor of Psychiatry

University of Birmingham

UNITED KINGDOM

View details

John Deakin

The University of Manchester

UNITED KINGDOM

View details

Alan K. Davis

Johns Hopkins University

UNITED STATES

View details

Robin Carhart-Harris

University of Oxford

UNITED KINGDOM

View details

Michael Bloomfield

UNITED KINGDOM

View details

David J. Nutt

Imperial College London

UNITED KINGDOM

View details

Simon B. Goldberg

Assistant Professor

University of Wisconsin-Madison

UNITED STATES

View details

Iro Boura

University of Crete

GREECE

View details

Hannes Kettner

Imperial College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Erritzoe

Research Interests

Explore related searches

Contact this professor

Articles (10)

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: a systematic review and individual participant data meta-analysis

A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences

Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca

Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge

Human brain effects of DMT assessed via EEG-fMRI

Psychedelics therapeutics: What we know, what we think, and what we need to research

Body mass index (BMI) does not predict responses to psilocybin

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample

Collaborators (14)

Abhishekh Ashok

Philip Corlett

Danilo Arnone

Per Carlbring

Sameer Jauhar

Rachel Upthegrove

John Deakin

Alan K. Davis

Robin Carhart-Harris

Michael Bloomfield

David J. Nutt

Simon B. Goldberg

Iro Boura

Hannes Kettner

Make your next move.